News
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.
According to a study published in Science Robotics, an international team led by Empa and EPFL researchers investigated how ...
As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...
A new fiber-optic device enables rapid, microscope-free detection of biomarkers using a gliding motility assay. The platform ...
A study shows recycled concrete powders can replace up to 50% of Portland cement in 3D-printed mixes—cutting CO2 emissions by ...
The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results